Artículos del autor

solaci

Structural heart disease

Low Gradient Aortic Stenosis: Is Invasive Assessment Viable?

There is an important group of patients presenting low flow, low-gradient severe aortic stenosis (defined as mean...
solaci -
Structural heart disease

Redo Surgical Aortic Valve Replacement after Prior Transcatheter vs Surgical Aortic Valve Replacement: A Growing Population

Transcatheter aortic valve replacement (TAVR) has evolved since it was first implemented, and it is now also...
solaci -
Structural heart disease

BASILICA: a Complex Strategy, Yet Safe

Coronary artery obstruction (CAO) after TAVR is rare, but it entails extremely high mortality (50% or more),...
solaci -
Structural heart disease

Evolute Low Risk at 3 Years: Promising Outcomes

Transcatheter aortic valve replacement has shown important benefits but one of its biggest challenges is showing its...
solaci -
Peripheral vascular disease

CLOUT Registry: Thrombectomy in TVP with ClotTriever

Safety and efficacy of the ClotTriever device in extended deep vein thrombosis.  The endovascular treatment of thromboembolic disease...
solaci -
Institutional News

Welcome to SOLACI-SBHCI 2023 | August 2-4 2023, Rio de Janeiro

MD Helio Roque Figueira, President of SOLACI-SBHCI 2023, is inviting the entire Latin American interventionist community to...
solaci -
Coronary disease

PICCOLETO-II: Drug-Coated Balloons in Small Vessels

Use of drug-coated balloons vs. drug-eluting stents in small caliber vessels. The constant advancements in coronary device technology...
solaci -
Femoropopliteal

Retrograde Tibial Access for Endovascular Treatment of Femoropopliteal Occlusions: Is it a Safe Strategy?

Endovascular recanalization of femoropopliteal occlusions continues to be one of the initial therapeutic strategies to treat this...
solaci -